GABA-Producing Bacteria as Potential Psychobiotics in Gut-Brain Axis Regulation.

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system (CNS), crucial for neural balance, mood regulation, and stress response.
• Gut microbiome research reveals bacterial species, including Lactobacillus, Bifidobacterium, and Bacteroides, possess glutamate decarboxylase (GAD) systems for GABA production.
• Microbially-derived GABA impacts the microbiota-gut-brain (MGB) axis via neural, endocrine, and immune pathways essential for homeostasis.

Purpose of the Study:

• To review current knowledge on GABA-producing bacterial strains from human gut and food environments.
• To explore the potential of these bacteria as psychobiotics for modulating gut-brain communication and mental health.

Main Methods:

• Literature review of metagenomic studies and research on GABA-producing bacteria.
• Analysis of bacterial genera known for GABA production (Lactobacillus, Bifidobacterium, Bacteroides).
• Examination of evidence linking microbial GABA to the MGB axis and mental health outcomes.

Main Results:

• Identified various bacterial species from gut and food sources capable of producing GABA via GAD systems.
• Highlighted the role of microbially produced GABA in influencing the MGB axis.
• Summarized emerging evidence for GABA-producing bacteria (psychobiotics) in improving neurotransmitter balance, immune function, gut barrier integrity, and alleviating anxiety/depression.

Conclusions:

• GABA-producing bacteria represent a promising area of research for mental health interventions.
• These psychobiotics have the potential to modulate gut-brain communication for improved neurological and psychological well-being.
• Further research into GABA-producing strains could lead to novel therapeutic strategies for mental health disorders.